Suppr超能文献

急性缺血性脑卒中后出血性转化的预测因素及早期转归。

Predictors and early outcome of hemorrhagic transformation after acute ischemic stroke.

机构信息

Department of Neurology, UniversitätsMedizin Mannheim, University of Heidelberg, Mannheim, Germany.

出版信息

Cerebrovasc Dis. 2011;32(4):334-41. doi: 10.1159/000331702. Epub 2011 Sep 15.

Abstract

BACKGROUND

Hemorrhagic transformation (HT) after acute ischemic stroke is frequently detected using magnetic resonance imaging (MRI), in particular in patients treated with tissue plasminogen activator (tPA). Knowledge about causes and early clinical consequences of HT mostly arises from computed tomography-based studies. We analyzed potential predictors and early outcome of HT after stroke detected by MRI with T(2)-weighted gradient echo sequences (T(2)-MRI).

METHODS

122 consecutive stroke patients (mean age 65.5 years, 41% women) who underwent T(2)-MRI within 6-60 h after stroke onset were included. 25.4% of patients were treated with tPA; the overall detection rate of HT on T(2)-MRI was 20.5%. Potential predictors of HT, such as age, sex, blood pressure, stroke etiology, prior antithrombotic medication, neurological deficit on admission, tPA treatment, and specific MRI findings, were analyzed. In addition, we evaluated the effect of HT on early outcome: a decrease of >4 points on the National Institute of Health Stroke Scale (NIHSS) on day 5 was considered early improvement, and an increase of >4 points was considered early deterioration.

RESULTS

The main predictor for occurrence of HT was tPA treatment (48.4 vs. 11.1%; odds ratio 7.50; 95% confidence interval 2.9-19.7; p < 0.001). Furthermore, the development of HT was associated with a severer neurological deficit on admission (mean NIHSS score 9.9 vs. 5.9; p = 0.003), and territorial infarction (88 vs. 58.8%; p = 0.007). 19 patients (15.6%) showed early improvement which was associated with the occurrence of HT (p = 0.011) and tPA treatment (p < 0.001).

CONCLUSIONS

HT is a frequent finding on T(2)*-MRI in patients with acute ischemic stroke associated with tPA treatment, territorial infarction and severer neurological deficits on admission. However, HT does not cause clinical deterioration; it is rather related to a favorable early outcome likely reflecting early recanalization and better reperfusion in these patients.

摘要

背景

急性缺血性脑卒中后常通过磁共振成像(MRI)检测到出血性转化(HT),特别是在接受组织型纤溶酶原激活剂(tPA)治疗的患者中。关于 HT 的原因和早期临床后果的知识主要来自基于计算机断层扫描的研究。我们分析了通过 T(2)-加权梯度回波序列(T(2)-MRI)检测到的急性缺血性脑卒中患者 MRI 后 HT 的潜在预测因素和早期预后。

方法

纳入 122 例连续脑卒中患者(平均年龄 65.5 岁,41%为女性),在脑卒中发病后 6-60 h 内行 T(2)-MRI。25.4%的患者接受了 tPA 治疗;T(2)-MRI 上 HT 的总检出率为 20.5%。分析 HT 的潜在预测因素,如年龄、性别、血压、脑卒中病因、既往抗血栓药物治疗、入院时神经功能缺损、tPA 治疗以及特定的 MRI 表现。此外,我们评估了 HT 对早期预后的影响:第 5 天 NIHSS 评分下降>4 分为早期改善,增加>4 分为早期恶化。

结果

HT 发生的主要预测因素是 tPA 治疗(48.4% vs. 11.1%;优势比 7.50;95%置信区间 2.9-19.7;p<0.001)。此外,HT 的发生与入院时更严重的神经功能缺损(平均 NIHSS 评分 9.9 vs. 5.9;p=0.003)和区域性梗死(88% vs. 58.8%;p=0.007)相关。19 例(15.6%)患者早期改善,与 HT 的发生(p=0.011)和 tPA 治疗(p<0.001)相关。

结论

急性缺血性脑卒中患者 T(2)*-MRI 上 HT 常见,与 tPA 治疗、区域性梗死和入院时更严重的神经功能缺损相关。然而,HT 并不会导致临床恶化,而是与有利的早期预后相关,这可能反映了这些患者的早期再通和更好的再灌注。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验